These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33400697)

  • 1. Development of Glycerol-Rose Bengal-Polidocanol (GRP) foam for enhanced sclerosis of a cyst for cystic diseases.
    Jeong S; Kim S; Choi Y; Jung HN; Lee K; Park MH
    PLoS One; 2021; 16(1):e0244635. PubMed ID: 33400697
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Foam sclerotherapy for a symptomatic hepatic cyst: a preliminary report.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    Cardiovasc Intervent Radiol; 2014 Jun; 37(3):800-4. PubMed ID: 24170168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of sclerotherapy with polidocanol foam in comparison with fluid sclerosant in the treatment of first-grade haemorrhoidal disease: a randomised, controlled, single-blind, multicentre trial.
    Moser KH; Mosch C; Walgenbach M; Bussen DG; Kirsch J; Joos AK; Gliem P; Sauerland S
    Int J Colorectal Dis; 2013 Oct; 28(10):1439-47. PubMed ID: 23775099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interim results of bleomycin-polidocanol foam sclerotherapy as a highly efficient technique for venous malformations.
    Yang X; Chen H; Gu H; Jin Y; Hu L; Hua C; Wang Y; Sun Y; Yu W; Lin X
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1066-1073. PubMed ID: 32284311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the efficacy of foam sclerosant after addition of glycerine on human great saphenous vein: histological and immunohistochemical study.
    Sawaby A; Maklad S; Atta I; El Abd A; Mady MM; Solaiman A
    Ann R Coll Surg Engl; 2021 Jun; 103(6):452-458. PubMed ID: 33851890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-blind, randomized study comparing chromated glycerin, polidocanol solution, and polidocanol foam for treatment of telangiectatic leg veins.
    Kern P; Ramelet AA; Wutschert R; Bounameaux H; Hayoz D
    Dermatol Surg; 2004 Mar; 30(3):367-72; discussion 372. PubMed ID: 15008862
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preliminary Experience With More Stable Polidocanol Foam in Sclerotherapy of Head and Neck Venous Malformations.
    Chen AW; Liu SH; Huang YY; Wang T
    Dermatol Surg; 2018 Nov; 44(11):1421-1426. PubMed ID: 29933299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
    Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
    Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of sclerotherapy with polidocanol foam in the treatment of second-degree haemorrhoidal disease - a video vignette.
    Lobascio P; Minafra M; Laforgia R; Giove C; Trompetto M; Gallo G
    Colorectal Dis; 2019 Feb; 21(2):244-245. PubMed ID: 30485654
    [No Abstract]   [Full Text] [Related]  

  • 12. Sclerotherapy using 2 % polidocanol foam in the treatment of hemorrhoidal disease - a single-center experience.
    Figueiredo LM; Bordalo Ferreira F; Rafael MA; Oliveira AM
    Rev Esp Enferm Dig; 2022 Mar; 114(3):185-186. PubMed ID: 34517712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous treatment of symptomatic non-parasitic hepatic cysts. Initial experience with single-session sclerotherapy with polidocanol.
    Spârchez Z; Radu P; Zaharie F; Al Hajjar N; Sparchez M
    Med Ultrason; 2014 Sep; 16(3):222-8. PubMed ID: 25110763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy with 3% polidocanol foam to treat second-degree haemorrhoidal disease: Three-year follow-up of a multicentre, single arm, IDEAL phase 2b trial.
    Gallo G; Picciariello A; Pietroletti R; Novelli E; Sturiale A; Tutino R; Laforgia R; Moggia E; Pozzo M; Roveroni M; Bianco V; Realis Luc A; Giuliani A; Diaco E; Naldini G; Trompetto M; Perinotti R; D'Andrea V; Lobascio P
    Colorectal Dis; 2023 Mar; 25(3):386-395. PubMed ID: 36268758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel developments in foam sclerotherapy: Focus on Varithena® (polidocanol endovenous microfoam) in the management of varicose veins.
    Star P; Connor DE; Parsi K
    Phlebology; 2018 Apr; 33(3):150-162. PubMed ID: 28166694
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Properties of polidocanol foam in view of its use in sclerotherapy.
    Nastasa V; Samaras K; Ampatzidis Ch; Karapantsios TD; Trelles MA; Moreno-Moraga J; Smarandache A; Pascu ML
    Int J Pharm; 2015 Jan; 478(2):588-96. PubMed ID: 25433198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polidocanol foam stability in terms of its association with glycerin.
    Rial R; Hervas LS; Monux G; Galindo A; Martin A; Hernando M; Martinez I; Hernando A; Serrano FJ
    Phlebology; 2014 Jun; 29(5):304-9. PubMed ID: 23470491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
    Markovic JN; Nag U; Shortell CK
    J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.